Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti.
暂无分享,去创建一个
V. Godfrey | J. Roberts | M. Karin | R. Johnson | M. Karin | L. Feng | T. Schwarz | G. Krähn-Senftleben | C. Makris | Jaclyn L. Roberts | T. Schwarz | T. Takahashi | Li-Yia Feng | R. Johnson | Takayuki Takahashi | T. Takahashi | R. Johnson | R. Johnson | Gertraud Krähn-Senftleben
[1] T. Mak,et al. Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. , 2000, Genes & development.
[2] Stuart K. Calderwood,et al. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine , 2000, Nature Medicine.
[3] H. Kolb,et al. Cutting Edge: Heat Shock Protein 60 Is a Putative Endogenous Ligand of the Toll-Like Receptor-4 Complex1 , 2000, The Journal of Immunology.
[4] R. V. van Leeuwen,et al. Incontinentia Pigmenti: An Extensive Second Episode of a “First‐Stage” Vesicobullous Eruption , 2000, Pediatric dermatology.
[5] David M. Rothwarf,et al. The NF-κB Activation Pathway: A Paradigm in Information Transfer from Membrane to Nucleus , 1999, Science's STKE.
[6] T. Deerinck,et al. The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of Apoptosis , 1999, The Journal of experimental medicine.
[7] T. Deerinck,et al. Abnormal Morphogenesis But Intact IKK Activation in Mice Lacking the IKKα Subunit of IκB Kinase , 1999 .
[8] S. Akira,et al. Limb and skin abnormalities in mice lacking IKKalpha. , 1999, Science.
[9] Inder M. Verma,et al. Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene , 1999 .
[10] D. Goeddel,et al. Embryonic Lethality, Liver Degeneration, and Impaired NF-κB Activation in IKK-β-Deficient Mice , 1999 .
[11] K. Jeang,et al. Isolation of full-length cDNA and chromosomal localization of human NF-kappaB modulator NEMO to Xq28. , 1999, Journal of biomedical science.
[12] E. Zandi,et al. IKK-γ is an essential regulatory subunit of the IκB kinase complex , 1998, Nature.
[13] Ebrahim Zandi,et al. Direct Phosphorylation of IκB by IKKα and IKKβ: Discrimination Between Free and NF-κB-Bound Substrate , 1998 .
[14] G. Courtois,et al. Complementation Cloning of NEMO, a Component of the IκB Kinase Complex Essential for NF-κB Activation , 1998, Cell.
[15] A. Scheuerle. Male cases of incontinentia pigmenti: case report and review. , 1998, American journal of medical genetics.
[16] P. Khavari,et al. Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB , 1998 .
[17] B. Morrow,et al. Incontinentia pigmenti in a newborn male infant with DNA confirmation. , 1998, American journal of medical genetics.
[18] M J May,et al. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.
[19] Matthias Mann,et al. IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation , 1997 .
[20] E. Zandi,et al. The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation , 1997, Cell.
[21] David M. Rothwarf,et al. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.
[22] D. Goeddel,et al. Identification and Characterization of an IκB Kinase , 1997, Cell.
[23] P. Leder,et al. Transposon-generated ‘knock-out’ and ‘knock-in’ gene-targeting constructs for use in mice , 1997, Current Biology.
[24] M. Karin,et al. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.
[25] S. Ma,et al. Transcriptional control of K5, K6, K14, and K17 keratin genes by AP-1 and NF-kappaB family members. , 1997, Gene expression.
[26] T. McCalmont,et al. Eosinophilic and neutrophilic spongiosis: clues to the diagnosis of immunobullous diseases and other inflammatory disorders. , 1996, Seminars in cutaneous medicine and surgery.
[27] Marty W. Mayo,et al. TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.
[28] David Baltimore,et al. An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.
[29] Seamus J. Martin,et al. Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.
[30] Michael Karin,et al. Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death , 1996, Cell.
[31] A. Ciccodicola,et al. Long-range sequence analysis in Xq28: thirteen known and six candidate genes in 219.4 kb of high GC DNA between the RCP/GCP and G6PD loci. , 1996, Human molecular genetics.
[32] David Baltimore,et al. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB , 1995, Nature.
[33] Y. Xia,et al. Interleukin-1 alpha stimulates KC synthesis in rat mesangial cells: glucocorticoids inhibit KC induction by IL-1. , 1994, The American journal of physiology.
[34] J. Roder,et al. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[35] D. Donnai,et al. Incontinentia pigmenti (Bloch-Sulzberger syndrome). , 1993, Journal of medical genetics.
[36] D. Sinnett,et al. The gene for incontinentia pigmenti is assigned to Xq28. , 1989, Genomics.
[37] R. G. Carney. Incontinentia pigmenti. A world statistical analysis. , 1976, Archives of dermatology.